Clinical outcomes of HER2-positive metastatic breast cancer patients with brain metastasis treated with lapatinib and capecitabine: an open-label expanded access study in Korea

BACKGROUND: To evaluate efficacy in patients with brain metastasis (BM) on entry into the lapatinib expanded access program (LEAP). METHODS: LEAP is a worldwide, single-arm, open-label study. HER2-positive, locally-advanced or metastatic breast cancer patients with progression after an anthracycline...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Ro, Jungsil, Park, Sohee, Kim, Sung- Bae, Kim, Tae You, Im, Young Hyuk, Rha, Sun Young, Chung, Joo Seop, Moon, Hanlim, Santillana, Sergio
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2012
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3480888/
https://ncbi.nlm.nih.gov/pubmed/22839200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-322
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky